The present invention relates to an implant, a method and a device for producing an implant of this type.
An implant, such as that described in EP 1 153 581 A1, is known. The narrowing of vessel sections (restenosis) following a stent implant continues to be a major clinical problem in spite of numerous further developments in this field. In this context, it is generally acknowledged that neointimal hyperplasia is the chief cause of restenosing following a stent implant. Although the mechanisms responsible for the occurrence of restenosis have not yet been fully clarified, the damage to the endothelium and the smooth muscle cells of the vessel wall, which occurs in the course of a stent implant, the reduced fit (compliance) due to the rigid stent structures and the change in shear stress at the vessel wall (wall shear stress) of the stented vessel sections are regarded as triggers of neointimal hyperplasia and, therefore, of restenosis.
Moreover, it is known that stented vessel sections not only lead to a change in the shear stress at the vessel wall, but also can promote the undesirable formation of thrombi due to changes in the haemodynamics of the natural blood flow. It is furthermore known that the formation of restenoses may depend on the stent geometry. It is generally assumed that a low shear stress at the vessel wall promotes neointimal hyperplasia.
According to the abovementioned EP 1 153 581 B1, a stent in the inside of which a flow cylinder is arranged centrally in the longitudinal direction of the stent is proposed in this connection. Due to the reduced flow diameter between the flow cylinder and the surrounding wall of the stent, the flow rate in the stent is increased, so that a steeper flow profile is established in the vicinity of the wall. Needless to say, fixing of the flow cylinder in the stent presents production problems. In addition, the flow cylinder impairs the flexibility of the stent.
WO 03/1057328 discloses a braided multilayer stent which has a core in the inside to influence the haemodynamics. There are also production problems with this stent.
The present invention is based on the object of providing an implant with a wall element which is comparatively easy to produce and is improved with respect to a reduction in restenosis following an implant. The object of the present invention is furthermore to provide a method and a device for producing an implant of this type.
According to the present invention, this object is achieved with respect to the implant, the method and the device described in the appending claims.
The present invention is accordingly based on the idea of providing an implant with a wall element which when implanted comes into contact with a fluid, the wall element being adapted to influence the flow behaviour of the fluid. According to the present invention, the wall element has a non-continuous profile.
The present invention pursues a different approach to that in the case of stents which have the effect of a reduction in the effective flow diameter due to a cylinder arranged in the flow channel. In the implant according to the present invention, the wall or a wall element is modified, and in particular by a non-continuous profiling thereof which influences the flow behaviour. This has the advantage that no additional flow body, such as the flow cylinder, has to be connected to the wall in an elaborate manner. Rather, a narrowing in cross-section is achieved by the wall element itself, and in particular by non-continuous profiling thereof.
The present invention has the advantage, in particular, that by the influencing of the haemodynamics in the blood stream, in particular by the increase in the flow rate, the shear stress at the vessel wall is increased and neointimal hyperplasia and restenosis are thus inhibited. Early endothelialization of the implant is furthermore promoted, which likewise has a positive effect since the occurrence of neointimal hyperplasia is thereby counteracted. The influencing of the flow dynamics, in particular the increase in flow rate, moreover inhibits the formation of thrombi.
A further advantage of the present invention is that the implant is particularly suitable for treatment of aneurysms. The narrow mesh width of aneurysm stents required for covering the aneurysm leads to adverse side effects, such as restenosis, and to the formation of thrombi. These undesirable side effects are avoided or at least occur to a lesser extent by the non-continuous profiling of the wall element.
The present invention is not limited to stents, in particular intraluminal stents, but includes implants generally, in particular medical or endovascular implants with an incident flow of fluid, or which generally have a flow conduction function, such as stent grafts, protection filters, etc.
In a preferred embodiment of the present invention, the wall element has profile elements with incident flow surfaces arranged non-continuously. The incident flow surfaces are not connected continuously to one another, but have generally abrupt transitions, so that overall a non-continuous profile or a non-continuous contouring of the inside of the wall element results. A wall element of this type or an implant with a wall element of this type can be produced easily and with comparatively low costs.
A particularly effective influencing of the flow behaviour is achieved if the incident flow surfaces have a main orientation which essentially extends in the direction of flow.
The incident flow surfaces can in each case be arranged, with respect to the wall element, with a tilt and/or a convex curve and/or a concave curve. By the different formation of the incident flow surfaces, a different influencing of the flow behaviour can be established.
In a preferred embodiment of the present invention, the non-continuous profiling of the wall element is achieved by the incident flow surfaces each having an end at a distance from the wall element, in particular a free end, which when implanted projects into the fluid flow. The profile elements here can form a wall element profile which is sawtooth-like in cross-section. A profile cross-section of this type can be produced in a simple manner.
The profile elements can form a pattern, in particular a helical pattern. As a result of the formation of a pattern, a desired flow behaviour is imprinted on the fluid over a longer flow distance.
The wall element can include a grid structure with grid elements, such as struts, end curves, connectors and the like, with at least some of the grid elements for formation of the incident flow surfaces each being arranged in a different plane to an inner surface of the wall element. This embodiment of the present invention is particularly suitable for stents and is distinguished by a production-friendly construction. No additional separate elements which are connected to the stent to form a wall profile are required for this. Rather, the non-continuous profile is formed by the grid elements already present, which are modified such that they are each arranged in a different plane to the inner surface of the wall element. The inner surface of the wall element is, therefore, not continuously flat, but has generally a contour of non-continuous profile.
The process according to the present invention for producing an implant of this type is based on the wall element having a non-continuous profile for influencing the flow behaviour of a fluid which comes into contact with the wall element when implanted. For this, the wall element can be formed locally such that non-continuously arranged incident flow surfaces of the profile elements are formed.
For production of an implant of this type, a device which comprises a moulding with a contour of non-continuous profile is proposed according to the present invention.
The present invention is explained in the following with further details with the aid of embodiment examples with reference to the attached drawings in diagram form.
The foregoing summary, as well as the following detailed description of the invention, will be better understood when read in conjunction with the appended drawings. For the purpose of illustrating the invention, there are shown in the drawings embodiments which are presently preferred. It should be understood, however, that the invention is not limited to the precise arrangements and instrumentalities shown.
In the drawings:
Certain terminology is used in the following description for convenience only and is not limiting. The words “inner,” “outer,” “inwardly” and “outwardly” refer to directions toward and away from, respectively, the geometric center of the implant or device and designated parts thereof. Additionally, the terms “a,” “an” and “the,” as used in the specification, mean “at least one.” The terminology includes the words above specifically mentioned, derivatives thereof, and words of similar import.
Referring to the drawings in detail, wherein like numerals indicate like elements throughout, there is shown in
While the inner surface 110a of the stent according to
The particular inner surface 10a of the projecting grid elements 14a functions here as an incident flow or deflection surface 12 for the fluid flow. The incident flow surfaces 12 of the various grid elements 14a and of the profile elements 11 are preferably arranged non-continuously and are interrupted at least in the profile space, i.e. outside the non-profiled original generated surface. This results generally in an abrupt or non-continuous transition between the profile elements 11.
The incident flow surfaces 12 have a main or preferred orientation which essentially extends in the direction of flow, as shown by the arrow S in
The grid structure 14 of the stent according to one preferred embodiment of the present invention is shown in
In other words, the inner surfaces 10a of the profiled and non-profiled regions of the wall elements 10 form intersecting planes. In the present example, the profile elements 11 are part of the wall element 10 and differ from the wall element 10 by the inwards projecting or exposed position or arrangement.
The forming, i.e. the bending, of the grid elements 14a can take place in the region between two end curves 16, 16a bordering a strut 15. The strut 15 being bent in the vicinity of one of the two end curves or, for example, in the middle of the strut, depending on how large the incident flow surface 12 thereby achieved is to be.
This principle can be applied to the entire stent, it being possible to achieve various patterns, for example a helical or spiral pattern, by appropriate arrangement of the profiling, i.e. the bent elements. In this context, the profiling extends over a certain length or part length of the stent.
The hollow cylindrical overall shape of the stent is retained.
Overall, the profile elements 11 form local and non-continuously arranged constrictions of the flow diameter of the implant when implanted.
To produce the implant or the stent according to
The wall element 10 or the implant can preferably be produced from a shape memory material, such as nitinol. This has the advantage that when the implant is compressed the wall element 10 can be forced into the same area as the other grid elements 14a which, when expanded, are responsible for the non-continuous profiling of the wall element. The implant can, therefore, be constructed without an additional increase in the size of the insertion diameter. By using a shape memory material for the wall element 10, the three-dimensional structure (in comparison with the two-dimensional structure of the non-profiled wall element) produced by the wall element when expanded is reduced to the previous two-dimensional form on insertion of the stent.
It will be appreciated by those skilled in the art that changes could be made to the embodiments described above without departing from the broad inventive concept thereof. It is understood, therefore, that this invention is not limited to the particular embodiments disclosed, but it is intended to cover modifications within the spirit and scope of the present invention as defined by the appended claims.
Number | Date | Country | Kind |
---|---|---|---|
10 2007 015 462.5 | Mar 2007 | DE | national |
This application is a Section 371 of International Application No. PCT/EP2008/002509, filed Mar. 28, 2008, which was published in the German language on Oct. 9, 2008, under International Publication No. WO 2008/119520 A1 and the disclosure of which is incorporated herein by reference.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/EP08/02509 | 3/28/2009 | WO | 00 | 4/1/2010 |